ロード中...

Pharmacokinetics of Alemtuzumab in Pediatric Patients Undergoing ex vivo T-Cell Depleted Haploidentical Hematopoietic Cell Transplantation

PURPOSE: Alemtuzumab is a humanized monoclonal antibody against CD52 which is predominantly present on T- and B-lymphocytes. Alemtuzumab has been used as part of conditioning regimens for prophylaxis against rejection and GVHD. While the mechanism of action is well-understood, the pharmacokinetics o...

詳細記述

保存先:
書誌詳細
出版年:Cancer Chemother Pharmacol
主要な著者: Bhoopalan, Senthil Velan, Cross, Shane J., Panetta, John C., Triplett, Brandon M.
フォーマット: Artigo
言語:Inglês
出版事項: 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7735192/
https://ncbi.nlm.nih.gov/pubmed/33037919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-020-04160-7
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!